Stem-Cell-Based Tumorigenesis in Adult Drosophila
1The Basic Research Laboratory, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD, United States.
Current Topics in Developmental Biology
|January 7, 2017
Summary
Cancer stem cells (CSCs) drive tumor growth and therapy resistance. Drosophila studies reveal CSC biology, offering potential for new cancer treatments.
Area of Science:
- Developmental Biology
- Cancer Biology
- Genetics
Background:
- Cancer stem cells (CSCs) are implicated in tumor propagation, relapse, and patient mortality.
- CSCs share properties with normal stem cells but possess distinct tumorigenic capabilities and therapy resistance.
- The underlying biology of CSCs remains incompletely understood.
Purpose of the Study:
- To review how stem cell tumors are initiated and propagated in Drosophila.
- To discuss differences between normal and tumorigenic stem cells using Drosophila models.
- To elucidate the biology of therapy resistance in cancer stem cells.
Main Methods:
- Review of studies on stem-cell tumors in Drosophila, focusing on niche appropriation and stem-cell competition.
- Analysis of RasV12-transformed stem-cell tumors in the Drosophila kidney to differentiate normal and tumorigenic stem cells.
- Examination of stem cell resistance and sensitivity to death inducers in Drosophila models.
Main Results:
- Drosophila models illustrate CSC tumor initiation via niche appropriation and competition.
- Studies highlight distinctions between normal and tumorigenic stem cells, particularly in RasV12-transformed tumors.
- Mechanisms of therapy resistance in CSCs have been elucidated through studies on stem cell death sensitivity.
Conclusions:
- Drosophila serves as a valuable model for understanding cancer stem cell biology.
- Insights from Drosophila studies can inform the development of novel cancer therapies.
- Future screens using Drosophila neoplastic stem cell tumor models may identify new anti-cancer compounds.
